Sign In
Buy CMRX
$8.54
+0 (+0%)
At Close: Jul 18, 2025
Chimerix Reports Initiation Of Phase 2/3 Study Of DSTAT In Acute Lung Injury For Patients With Severe Coronavirus Infection
11:11am, Wednesday, 29'th Apr 2020Wall Street Analysts Are Bullish on Top Healthcare Picks
11:11am, Wednesday, 29'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Chimerix (CMRX) and Sarepta Therapeutics (SRPT) with
Wall Street Analysts Are Bullish on Top Healthcare Picks
11:10am, Wednesday, 29'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Chimerix (CMRX
Chimerix Announces Initiation of a Phase 2/3 Study of DSTAT in Acute Lung Injury for Patients with Severe COVID-19
11:00am, Wednesday, 29'th Apr 2020
FDA Clearance to Proceed with Phase 2/3 Randomized, Double-Blind, Placebo Controlled Study Mechanisms of Action May Address Overactive Inflammatory Response, Including.
Chimerix (NASDAQ:CMRX) Upgraded at ValuEngine
06:16am, Wednesday, 29'th Apr 2020
Chimerix (NASDAQ:CMRX) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a research report issued on Wednesday, ValuEngine reports. Several other ana
Chimerix Announces Initiation of a Phase —/' Study of DSTAT in Acute Lung Injury for ...
12:00am, Wednesday, 29'th Apr 2020
Chimerix (DNRG), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that the Company has received clearance f
Chimerix Receives FDA Clearance for Rolling Submission of New Drug Application for ...
12:00am, Tuesday, 28'th Apr 2020Short Interest in Chimerix Inc (NASDAQ:CMRX) Decreases By 10.1%
05:54am, Thursday, 23'rd Apr 2020
Chimerix Inc (NASDAQ:CMRX) was the target of a large decline in short interest in March. As of March 31st, there was short interest totalling 1,720,000 shares, a decline of 10.1% from the March 15th t
Chimerix Inc (NASDAQ:CMRX) Shares Bought by AQR Capital Management LLC
08:22am, Sunday, 05'th Apr 2020
AQR Capital Management LLC boosted its holdings in shares of Chimerix Inc (NASDAQ:CMRX) by 246.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Ex
Edited Transcript of CMRX earnings conference call or presentation 25-Feb-20 1:30pm GMT
12:18pm, Thursday, 26'th Mar 2020
Q4 2019 Chimerix Inc Earnings Call
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) * Biomerica, Inc. (NASDAQ: BMRA) * Centogene NV (
